A prognostic nomogram based on LASSO Cox regression in patients with alpha-fetoprotein-negative hepatocellular carcinoma following non-surgical therapy.

Abstract

BACKGROUND:

Alpha-fetoprotein-negative hepatocellular carcinoma (AFP-NHCC) (< 8.78 ng/mL) have special clinicopathologic characteristics and prognosis. The aim of this study was to apply a new method to establish and validate a new model for predicting the prognosis of patients with AFP-NHCC.

METHODS:

A total of 410 AFP-negative patients with clinical diagnosed with HCC following non-surgical therapy as a primary cohort; 148 patients with AFP-NHCC following non-surgical therapy as an independent validation cohort. In primary cohort, independent factors for overall survival (OS) by LASSO Cox regression were all contained into the nomogram1; by Forward Stepwise Cox regression were all contained into the nomogram2. Nomograms performance and discriminative power were assessed with concordance index (C-index) values, area under curve (AUC), Calibration curve and decision curve analyses (DCA). The results were validated in the validation cohort.

RESULTS:

The C-index of nomogram1was 0.708 (95%CI: 0.673-0.743), which was superior to nomogram2 (0.706) and traditional modes (0.606-0.629). The AUC of nomogram1 was 0.736 (95%CI: 0.690-0.778). In the validation cohort, the nomogram1 still gave good discrimination (C-index: 0.752, 95%CI: 0.691-0.813; AUC: 0.784, 95%CI: 0.709-0.847). The calibration curve for probability of OS showed good homogeneity between prediction by nomogram1 and actual observation. DCA demonstrated that nomogram1 was clinically useful. Moreover, patients were divided into three distinct risk groups for OS by the nomogram1: low-risk group, middle-risk group and high-risk group, respectively.

CONCLUSIONS:

Novel nomogram based on LASSO Cox regression presents more accurate and useful prognostic prediction for patients with AFP-NHCC following non-surgical therapy. This model could help patients with AFP-NHCC following non-surgical therapy facilitate a personalized prognostic evaluation.

• Authors: Dongdong Zhou, Xiaoli Liu, Xinhui Wang, Fengna Yan, Peng Wang, Huiwen Yan, Yuyong Jiang, Zhiyun Yang
• Journal: BMC cancer (BMC Cancer) Vol. 21 Issue 1 Pg. 246 (Mar 08 2021) ISSN: 1471-2407 [Electronic] England
• PMID: 33685417 (Publication Type: Journal Article, Validation Study)

Chemical References

• AFP protein, human
• alpha-Fetoproteins

Topics

• Biopsy
• Carcinoma, Hepatocellular (blood, diagnosis, mortality, therapy)
• Female
• Follow-Up Studies
• Humans
• Kaplan-Meier Estimate
• Liver (diagnostic imaging, pathology)
• Liver Neoplasms (blood, diagnosis, mortality, therapy)
• Male
• Middle Aged
• Neoplasm Grading
• Neoplasm Staging
• Nomograms
• Prognosis
• ROC Curve
• Retrospective Studies
• Risk Factors
• Treatment Outcome
• alpha-Fetoproteins (analysis)